Temodar Capsule
Pricing Report NDC 0085-1417-02
Current Package Pricing Information
The latest wholesale acquisition cost for Temodar (NDC 0085-1417-02) is $1091.67094 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Jan 05, 2018.
As a a human prescription drug provided by Merck Sharp & Dohme Llc, this medication is distributed in a 5 PACKET in 1 CARTON / 1 CAPSULE in 1 PACKET (0085-1417-03) configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.
NADAC Pricing Summary
NADAC pricing snapshot for this package NDC
Acquisition Cost $1,091.67094 Per EA
Historical Pricing Trends & Acquisition Cost Benchmarks
Since May 2013, the NADAC wholesale price for (NDC ) has moved within a range of $538.10409 to $1,091.67094 per EA. Over this 4 years and 7 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.
$538.1041 - $1,091.6709
102.87% Variance
9.94%
| Date | Unit Price | Unit | Source | Method | Rate |
|---|---|---|---|---|---|
| Jan 05, 2018 | $1091.67094 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Jan 05, 2018 | $1091.67094 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Mar 23, 2017 | $992.95169 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Mar 23, 2017 | $992.95169 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Sep 22, 2016 | $903.34033 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Sep 22, 2016 | $903.34033 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Mar 24, 2016 | $827.93984 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Mar 24, 2016 | $827.93984 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Oct 08, 2015 | $759.57784 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Oct 08, 2015 | $759.57784 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Mar 18, 2015 | $696.86040 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Mar 18, 2015 | $696.86040 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Sep 18, 2014 | $639.32147 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Sep 18, 2014 | $639.32147 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| Mar 25, 2014 | $586.53346 | EA | C/I - Chain or Independent Pharmacy | Code 3 | B - Brand |
| Mar 25, 2014 | $586.53346 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
| May 23, 2013 | $538.10409 | EA | C/I - Chain or Independent Pharmacy | Code 4 | B - Brand |
Pricing Methodology Legend
- Code 3: The NADAC based on survey data has been adjusted to reflect changes in published pricing, or as a result of an inquiry to the help desk.
- Code 4: The NADAC was carried forward from the previous file.
Understanding NADAC Pricing Data
The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.
Important Price Distinction:
The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.
NADAC Pricing Data Last Updated on: July 08, 2026
